These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 25310424)
1. Multimodality imaging for characterization, classification, and staging of malignant pleural mesothelioma. Nickell LT; Lichtenberger JP; Khorashadi L; Abbott GF; Carter BW Radiographics; 2014 Oct; 34(6):1692-706. PubMed ID: 25310424 [TBL] [Abstract][Full Text] [Related]
2. Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET. Wang ZJ; Reddy GP; Gotway MB; Higgins CB; Jablons DM; Ramaswamy M; Hawkins RA; Webb WR Radiographics; 2004; 24(1):105-19. PubMed ID: 14730040 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of sequential co-registered PET+MR in comparison to PET/CT in local thoracic staging of malignant pleural mesothelioma. Martini K; Meier A; Opitz I; Weder W; Veit-Haibach P; Stahel RA; Frauenfelder T Lung Cancer; 2016 Apr; 94():40-5. PubMed ID: 26973205 [TBL] [Abstract][Full Text] [Related]
4. Multidetector CT Findings and Differential Diagnoses of Malignant Pleural Mesothelioma and Metastatic Pleural Diseases in Korea. Kim YK; Kim JS; Lee KW; Yi CA; Goo JM; Jung SH Korean J Radiol; 2016; 17(4):545-53. PubMed ID: 27390546 [TBL] [Abstract][Full Text] [Related]
5. Preoperative evaluation of patients with malignant pleural mesothelioma: role of integrated CT-PET imaging. Truong MT; Marom EM; Erasmus JJ J Thorac Imaging; 2006 May; 21(2):146-53. PubMed ID: 16770231 [TBL] [Abstract][Full Text] [Related]
6. Imaging in pleural mesothelioma: a review of the 11th International Conference of the International Mesothelioma Interest Group. Armato SG; Labby ZE; Coolen J; Klabatsa A; Feigen M; Persigehl T; Gill RR Lung Cancer; 2013 Nov; 82(2):190-6. PubMed ID: 24018024 [TBL] [Abstract][Full Text] [Related]
7. Integrated positron emission tomography-computed tomography does not accurately stage intrathoracic disease of patients undergoing trimodality therapy for malignant pleural mesothelioma. Pilling J; Dartnell JA; Lang-Lazdunski L Thorac Cardiovasc Surg; 2010 Jun; 58(4):215-9. PubMed ID: 20514576 [TBL] [Abstract][Full Text] [Related]
13. Morphologic and functional imaging of malignant pleural mesothelioma. Yamamuro M; Gerbaudo VH; Gill RR; Jacobson FL; Sugarbaker DJ; Hatabu H Eur J Radiol; 2007 Dec; 64(3):356-66. PubMed ID: 17954021 [TBL] [Abstract][Full Text] [Related]
14. Use of computed tomography and positron emission tomography/computed tomography for staging of local extent in patients with malignant pleural mesothelioma. Frauenfelder T; Kestenholz P; Hunziker R; Nguyen TD; Fries M; Veit-Haibach P; Husmann L; Stahel R; Weder W; Opitz I J Comput Assist Tomogr; 2015; 39(2):160-5. PubMed ID: 25354093 [TBL] [Abstract][Full Text] [Related]
15. What is the best way to diagnose and stage malignant pleural mesothelioma? Zahid I; Sharif S; Routledge T; Scarci M Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):254-9. PubMed ID: 21044972 [TBL] [Abstract][Full Text] [Related]
16. Early-stage Clinical Characterization of Malignant Pleural Mesothelioma. Negi Y; Kuribayashi K; Funaguchi N; Doi H; Mikami K; Minami T; Takuwa T; Yokoi T; Hasegawa S; Kijima T In Vivo; 2018; 32(5):1169-1174. PubMed ID: 30150440 [TBL] [Abstract][Full Text] [Related]
17. Imaging of mesothelioma. Gill RR Recent Results Cancer Res; 2011; 189():27-43. PubMed ID: 21479894 [TBL] [Abstract][Full Text] [Related]